4:10 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Citius Oncology Nasdaq/NYSE Compliance Notice
Citius Oncology received a formal extension from Nasdaq until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. To satisfy the rule, the company's common stock must close at or above $1.00 for at least ten consecutive business days. The stock continues to trade on the Nasdaq Capital Market under the symbol 'CTOR' while the company evaluates options to address the deficiency.
- Counterparty
- Nasdaq Stock Market LLC
- Term
- through April 19, 2027